A B S T R A C T Binding of human high density lipoproteins (HDL, d = 1.063-1.21) to cultured human fibroblasts and human arterial smooth muscle cells was studied using HDL subjected to heparin-agarose affinity chromatography to remove apoprotein (apo) E and B. Saturation curves for binding of apo E-free 1251_ HDL showed at least two components: low-affinity nonsaturable binding and high-affinity binding that saturated at -20 1Ag HDL protein/ml. Scatchard analysis of high-affinity binding of apo E-free 125I-HDL to normal fibroblasts yielded plots that were significantly linear, indicative of a single class of binding sites. Saturation curves for binding of both '251-HDL3 (d = 1.125-1.21) and apo E-free 1251-HDL to low density lipoprotein (LDL) receptor-negative fibroblasts also showed high-affinity binding that yielded linear Scatchard plots. On a total protein basis, HDL2 (d = 1.063-1.10), HDL3 and very high density lipoproteins (VHDL, d = 1.21-1.25) competed as effectively as apo E-free HDL for binding of apo E-free 1251-HDL to normal fibroblasts. Also, HDL2, HDL3, and VHDL competed similarly for binding of 1251_ HDL3 to LDL receptor-negative fibroblasts. In contrast, LDL was a weak competitor for HDL binding. These results indicate that both human fibroblasts and arterial smooth muscle cells possess specific high affinity HDL binding sites. As indicated by enhanced LDL binding and degradation and increased sterol synthesis, apo E-free HDL3 promoted cholesterol efflux from fibroblasts. These effects also saturated at HDL3 concentrations of 20 ,g/ml, suggesting that promotion of cholesterol efflux by HDL is mediated by binding to the high-affinity cell surface sites.
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INTRODUCTION
An important function of circulating lipoproteins is the transport of lipids between various tissues in the body. The main function of low density lipoprotein (LDL) appears to be the delivery of esterified cholesterol to cells (1) . This process is mediated by high affinity binding of LDL to a cell surface receptor specific for apoproteins (apo)' B and E, followed by uptake and degradation of the LDL particle. The exact role of high density lipoprotein (HDL) in cholesterol transport remains unknown. There is some evidence that HDL, as well as LDL, binds specifically to steroid hormone-producing tissues to deliver cholesterol for use in hormone synthesis (2) (3) (4) . It has been postulated that HDL serves to remove unesterified cholesterol from other extrahepatic cells, which is then esterified and either transferred to lower density lipoproteins or carried to the liver where the cholesterol is ultimately excreted in bile ("reverse cholesterol transport") (5) . This removal or efflux of cholesterol from extrahepatic cells may be mediated by the binding of HDL to the cells (6) . Prior studies of binding of HDL to extrahepatic cells has been confounded by the fact that HDL separated by the usual ultracentrifugal procedures is a heterogeneous group of particles containing, in addition to apo A-I and A-II, apo E, which binds avidly to the LDL receptor (7) . In this study, specific highaffinity binding of HDL devoid of apo E (apo E-free HDL) to extrahepatic cells, independent of the LDL receptor, was demonstrated and characterized, and the possible relationship of this binding to cholesterol efflux from cells was assessed.
METHODS
Cells. Normal human skin fibroblasts were grown from explants of punch biopsies of skin from the inner thighs of normal volunteers. LDL receptor-negative fibroblasts (GM488, GM2000) were obtained from the Human Genetic Mutant Cell Repository (Camden, NJ). Human arterial smooth muscle cells were grown from explants of intimalmedial segments of thoracic aorta obtained during vascular surgery by methods previously described (8) . Cells were grown in plastic tissue culture flasks in modified DulbeccoVogt medium (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) containing 10% pooled human serum at 370C in humidified incubators equilibrated with 5% CO2, 95% air. For most experiments, cells were trypsinized from stock flasks (two to eight passages) and seeded in 35-mm plastic petri dishes using 2 ml of medium ( 28 h. The bottom fraction was isolated and recentrifuged. Apo A-I, A-II, and B were determined by radioimmunodiffusion techniques (11, 12) .
Apo E-and apo B-free HDL and sterol-depleted HDL. Fractions of HDL that were devoid of apo E were prepared by affinity column chromatography. HDL was passed through a heparin-agarose affinity column, essentially as described by Weisgraber and Mahley (13) , prepared by the method of Mitchell et al. (14) . HDL was added to the column in 0.005 M imidazole buffer (pH 6.5) containing 0.015 M NaCl. After the unbound HDL fraction was eluted from the column, the bound HDL was removed by increasing the NaCl concentration to 1.0 M. Elution of protein was monitored by measurement of absorbance at 280 nm. To ascertain that apo E and B were completely removed from HDL, the unbound fraction was tested for its ability to compete for '2I-LDL binding to fibroblasts. It was assumed that these HDL preparations were devoid of apo E and B if HDL could not displace 1251-LDL from the cell surface at HDL protein concentrations of 100-fold greater than the LDL protein concentration.
Lipid-depleted HDL3 was prepared by heptane extraction as described by Krieger et al. (15) , except that the extractions were performed at 00 rather than at -10°C, and no lipids were added to the extracted lipoprotein. This procedure removed >60 and 80% of the HDL3 unesterified and esterified cholesterol content, respectively, without affecting the phospholipid content or apoprotein composition.
Binding of '251-LDL. For KH2PO4, 8 .0 g/liter NaCl, 2.16 g/liter Na2HPO4 -7H20). Serum-free medium containing 10 mM HEPES buffer (pH 7.4) plus 2 mg/ml albumin with 1251-LDL was added to the dishes (1 ml/dish) and the cells were incubated at 00-40C for 2 h. After 2 h the incubation medium was removed and discarded. The dishes were then rapidly washed four times with 2.0 ml of cold PBS containing 2 mg/ml albumin (wash medium), followed by two 10-min washes with the same medium, and one wash with cold PBS. Each dish then received 2.0 ml of cold 10 mM HEPES buffer (pH 7.4) containing 9.0 mg/ml NaCl and 4.0 mg/ml dextran sulfate. After 1 h, the dextran sulfate medium was removed and the cells were dissolved in 0.1 M NaOH for protein determinations. The amount of radioactivity released by dextran sulfate was assumed to represent receptor-bound '25I-LDL (16, 17) .
Binding of '25I-HDL. After cells were grown to confluence, the dishes were washed with sterile PBS once and then were preincubated for [12] [13] [14] [15] [16] [17] [18] h at 370C in serum-free medium plus 2 mg/ml albumin. This preincubation was performed to allow time for lipoproteins to dissociate from cell surface binding sites and for cell cholesterol metabolism to equilibrate. Cholesterol efflux is negligible in the presence of serum-free medium (17) . Cells were then washed once at room temperature with 2.0 ml wash medium and chilled at 4°C after the addition of another 2.0 ml wash medium. The cold wash was then removed and serum-free medium containing 2 mg/ml albumin, 10 mM HEPES (pH 7.4), and '25I-HDL was added to the dishes (1 ml/dish). The cells were incubated at 0°-4°C for 2 h. After 2 h, the incubation medium was removed and discarded. The dishes were then subjected to the same wash procedure as with LDL binding. After the final wash with PBS, the amount of '25I-HDL bound was assessed by two separate procedures. For the first procedure, each dish received 1.0 ml medium containing 0.05% trypsin plus EDTA and the dishes were incubated at 370C for 10 min. The trypsin was then neutralized by addition of medium containing serum and the cells were pelleted by centrifugation. The amount of '25I-radioactivity in the supernatant was assumed to represent bound 125I-HDL. The washed pellet was then dissolved in 0.1 N NaOH and an aliquot was counted for '25I-radioactivity, assumed to represent internalized 125I-HDL, and another aliquot was used for protein determinations as described by Lowry et (21) . After the incubation times indicated, the dishes were placed on ice, washed twice with ice-cold PBS. Cells were harvested with a teflon policeman into ice-cold CH3OH:H20 (2:1), the lipids were extracted with CHC13, and the amount of label incorporated into total sterol (sterol synthesis) or cholesterol esters was measured as previously described (21) . The amount of 125I-LDL degraded by fibroblasts was estimated from the appearance in the medium of TCA-soluble, noniodide radioactivity as previously described (8) .
RESULTS
To demonstrate whether the techniques used were yielding an accurate assessment of high-affinity binding of HDL, the release of radioactivity during washing, trypsinization, and cell digestion was monitored after incubation of cultured skin fibroblasts at 370C with 10 jg/ml 125J-HDL3 protein (Fig. 1) . The HDL3 subfraction was used because it contains very little apo E. After the fifth wash, essentially no radioactivity was found in the medium. Even when binding was performed with 100 jg/ml lmI-HDL3, the amount of 1251 radioactivity released in the sixth wash was <15% of the final cell-associated radioactivity (data not shown).
After the sixth wash, trypsinization of the cells resulted in a significant release of 125I-HDL3 from the cells (Fig.  1 ). Washing the cell pellet after trypsinization released very little additional HDL. After digestion of the cell pellet with NaOH, some further radioactivity was recovered. However FIGURE 1 Release of surface bound '25I-HDL3 by sequential washes. Normal fibroblasts were preincubated for 30 h in medium containing either 10% whole human serum (A) or 10% LDS (0), followed by an overnight preincubation with serum-free medium plus 2 mg/ml albumin (Methods). The cells were then incubated with 10 Ig/ml of 1251-HDL3 protein at 370C for 4 h. The medium was then removed and the routine washing procedure used in these binding experiments was performed (Methods). The amount of radioactivity released after each wash was determined. After the sixth wash, the cells were trypsinized and the amount of radioactivity released was measured. The cell pellet was then digested with NaOH and amount of radioactivity that had remained associated with the cells was determined.
presumably represented low-affinity, nonspecific binding (Fig. 3) . When the nonspecific component was subtracted from total binding, a high-affinity saturable component of binding was apparent. A Scatchard plot of the high-affinity binding was significantly linear (r = 0.79, P < 0.01) (Fig. 3, inset) , indicative of a single class of binding sites.
Another method for determination of binding of HDL to cells independent of the LDL receptor is the incubation of untreated fractions of HDL with cells lacking the LDL receptor. An ultracentrifugally isolated subfraction of HDL that contains very little apo E, HDL3, was iodinated and incubated with LDL receptor-negative fibroblasts (Fig. 4A) . Nonspecific binding was determined by calculation of the slope of binding between 100 and 400 ;g/ml of '25I-HDL3 protein in the medium and extrapolation back to zero. Subtraction of nonspecific binding from total binding again revealed a high-affinity, saturable component. In a separate experiment, binding of apo E-free 1251_ HDL to LDL receptor-negative fibroblasts was also determined (Fig. 4B) . Again, a high-affinity, saturable binding component was apparent, which provides further evidence that HDL binds to the cell surface with high affinity, independent of the LDL receptor. Scatchard analysis of the high-affinity binding of 1251-HDL3 (Table I ). In contrast, high-affinity apo E-free HDL binding was the same in the presence or absence of calcium, indicating that HDL binding was independent of calcium. Low-affinity, nonspecific binding of LDL and HDL was unaffected by the availability of calcium in the medium.
Binding of apo E-free 1"I-HDL to cultured human arterial smooth muscle cells was also tested (Fig. 5) (Fig. 7) .
It has been noted previously that HDL3 and VHDL can promote cholesterol efflux from cultured fibroblasts (21) 
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FIGURE 3 The effects of excess unlabeled apo E-free HDL on binding of apo E-free 1251-HDL to normal fibroblasts. Fibroblasts were incubated at 00C with increasing concentrations of apo E-free 1251-HDL plus (A) or minus (0) at least 50-fold excess unlabeled apo E-free HDL. Binding was measured as described for Fig. 2 (Fig. 8) . Furthermore, the addition of apo E-free HDL3 to medium containing 125I-LDL increased the cell's ability to degrade LDL during 24-h incubations (Fig. 8) . This enhancement of LDL degradation also saturated at "20 ug/ml HDL protein. The effect of HDL3 on LDL degradation was apparently due to sustained elevation of LDL receptor activity. Direct measurement of LDL receptor activity also demonstrated that HDL3 exerted its maximum enhancement at 20 M&g protein/ml (Fig. 8C) . In contrast, when cells were preincubated with LDS to deplete cells of cholesterol and up-regulate the LDL receptor, HDL3 had little additional effect on LDL receptor activities (Fig. 8C) . Thus, the effect of HDL3 on cell cholesterol homeostasis became maximal at an HDL3 concentration similar to that which saturated the high-affinity HDL binding sites on the cell surface.
One explanation for the saturation curves shown in Fig. 8 mote cholesterol efflux from fibroblasts (21) . Although increased LDL degradation by fibroblasts occurs in the presence of HDL3, addition of apo E-free HDL2 to medium containing 125I-LDL had little effect on LDL degradation (Fig. 10) . Furthermore, a mixture of HDL3 and apo E-free HDL2 (one-to-one, protein-toprotein) had less ability to enhance LDL degradation than did HDL3 alone (Fig. 10) . Apparently, apo E-free HDL2 can block the enhancement of LDL degradation promoted by HDL3.
A requirement for the involvement of specific binding for the promotion of cholesterol efflux by HDL is that the bound HDL must be readily displaced from the binding sites so that cholesterol can be transported away from the cell. To test this possibility, fibroblasts were first incubated at 00C with saturating (20, monolayers were then warmed to 370C and the fate of the prebound HDL was monitored ( Fig. 11A and B). With serum-and lipoprotein-free medium, nearly 40% of the bound (trypsin releasable) apo E-free '25I-HDL was displaced during the first 2 h of incubation. This displacement was increased to >60% when unlabeled apo E-free HDL was added to the medium. Nearly all of the displaced '25I radioactivity was recovered in the medium as TCA-insoluble derivatives, suggesting that release of intact HDL particles from the surface accounted for the displacement of prebound HDL. Virtually none of the apo E-free 125I-HDL was internalized or degraded by the cell. In contrast, prebound apo E-free '"I-HDL was not displaced if cells were maintained at 00C during the 4-h incubations ( Fig. lOC and D to the fibroblasts at 00C and subsequently released into medium at 370C, the released lmI-HDL was subjected to SDS-polyacrylamide gel electrophoresis (Methods). Sterol-depleted HDL3 (Pg protein/ml) Coomassie blue staining of electrophoretic gels of the original unlabeled apo E-free HDL preparation revealed two major bands corresponding to apo A-I and A-II (Fig. 12) . Iodination of the HDL preparation yielded particles that were predominantly labeled in apo A-I and A-II as evident from autoradiograms of the '25I-HDL gels (Fig. 12) . As determined on consecutive 5-mm slices of 125I-HDL gels, -60 and 30% of the radioactivity was associated with apo A-I and apo A-II, respectively, with no other radioactive peaks evident (data not shown). When the '25I-HDL was immunoprecipitated (22) , 92 and 75% of the radioactivity was precipitated by antibodies to apo A-I and A-II, respectively. These results suggest that most of the 125I_ HDL particles contained both apo A-I and A-II, but a small proportion of the apo A-I-containing particles were devoid of apo A-II (22) . When fibroblasts were incubated with medium containing '25I-HDL at 00C, thoroughly washed, and subsequently chase-incubated at 370C with medium containing unlabeled HDL (Methods), the radioactive material released from the cell surface had electrophoretic properties that were identical to the unincubated '25I-HDL (Fig. 12) . These results strongly suggest that fibroblasts bind and subsequently release the apo A-I-and A-Il-containing HDL particles without marked alteration of their protein composition.
DISCUSSION
Recent studies have demonstrated that HDL can bind to high-affinity sites on cells from a variety of different tissues, including rat adrenal gland (2, 3), rat testes (4), rat and canine liver (23) (24) (25) (26) , bovine endothelium (25) , and human skin fibroblasts (6, 28, 29) . The physiological significance of this HDL binding has yet to be elucidated. Binding of HDL to steroid hormone- FIGURE 11 The fate of apo E-free '251-HDL bound to fibroblasts at 0°C after subsequent incubations at 0°or 37°C.
Fibroblasts were incubated for 2 h at 0°C with 20,ug protein/ ml apo E-free '25I-HDL and thoroughly washed, as described in Methods for the HDL binding assay. Cold serum-free medium was added to each dish that contained 2 mg/ml albumin alone (@, A) or albumin plus 20 sg protein/ml unlabeled apo E-free HDL (0, A). One set of dishes was then warmed to 37°C (panels A and B), while the other set was maintained at 0°C (panels C and D). After the times indicated, the medium was collected (panels B and D), treated with TCA, and TCA-soluble (A, L) and -insoluble (0, 0) radioactivity was measured (Methods). The washed monolayers were then trypsinized (panels A and C), and trypsinreleasable (0, 0) and trypsin-resistant (A, A) radioactivity was measured (Methods).
producing tissues may act to supply cholesterol to the cell for steroid synthesis (2) (3) (4) . On the other hand, HDL binding to peripheral cells may promote cholesterol efflux for transport to the liver (5, 6, 21 HDL is a heterogenous lipoprotein fraction containing several different subpopulations of particles. Of these subpopulations, those containing apo E can bind avidly to the LDL receptor (7), which may have accounted for much of the observed cell-surface binding of whole HDL reported in some previous studies. To evaluate HDL binding to sites distinct from the LDL receptor, HDL was first subjected to heparin-agarose affinity chromatography to remove apo E-and apo Bcontaining particles (13) . When tested on normal fibroblasts, these apo E-free HDL preparations did not compete at all for LDL binding to the cell. As evident from autoradiograms of SDS electrophoresis gels, radiolabeling of apo E-free HDL with '"I yielded particles with >90% of the radioactivity associated with apo A-I and A-II. Cultured cells were then incubated with increasing concentrations of apo E-free '251-HDL with and without excess unlabeled apo E-free HDL. Saturation curves of the data from studies with cultured fibroblasts revealed two components of HDL binding. One (30) . Moreover, exposure of fibroblasts to pronase or concanavalin A had no effect on HDL binding (data not shown), whereas both agents alter binding of LDL to fibroblasts (30, 31) . Pronase-insensitive HDL binding to fibroblasts has also been described by Wu et (27) . The possibility that HDL binding by fibroblasts can be regulated is currently under investigation in our laboratory. Competitive binding studies indicated that, on a total HDL protein basis, unlabeled HDL2, HDL3, VHDL, and apo E-free HDL competed equally well for binding of apo E-free 125I-HDL to normal fibroblasts; and HDL2, HDL3, and VHDL competed to a similar extent for binding of 125I-HDL3 to receptor-negative fibroblasts. Based on the HDL apo A-I content, which constitutes 60-80% of the total protein, each HDL subfraction also appeared to compete to a similar extent for the same binding sites. However, competition curves for each HDL subfraction were markedly different when the results were plotted according to the apo A-II content (data not shown). Assuming that the binding ligand is a protein, these competitive binding studies suggest that apo A-I, rather than apo A-II, is the major ligand that binds to the high-affinity sites. The lipid composition of the different HDL subfractions appears to have little influence on their ability to compete for cell surface binding. Both the sterol and phospholipid to total protein ratios vary severalfold between subfractions. Moreover, extraction of sterol from HDL3 by heptane had little effect on its ability to compete for 1251-HDL3 binding to fibroblasts.
Binding of apo E-free HDL to the cell surface is readily reversible. When fibroblasts were warmed to 370C after apo E-free '25I-HDL was bound to the cell surface at 0°C, most of the surface bound radioactivity was displaced within 2 h in the presence of unlabeled apo E-free HDL. All of the radioactivity appeared as TCA-insoluble derivatives in the medium, while virtually none of the bound HDL was internalized or degraded by the cell. Even in the absence of unlabeled apo E-free HDL, a marked portion of the prebound apo E-free 125I-HDL was released from the cell surface. Based on comparison of autoradiograms of electrophoresis gels, the released 125I-HDL had the same properties as the original 125I-HDL and thus appeared to be unaltered in the process. In contrast, when cells were maintained at 0°C, the prebound HDL was not released from the cell surface regardless of the presence or absence of unlabeled apo E-free HDL. Reversibility of HDL (21, 36) . Results from this study indicate that apo E-free HDL3 can enhance the ability of fibroblasts to bind and degrade '-5I-LDL and to synthesize sterol from [14C]acetate. The effects of apo E-free HDL3 on these processes became maximal at a concentration of 20 ,g protein/ml, the same concentration that appeared to saturate the high-affinity sites that bind apo E-free HDL. Studies by Daniels et al. (33) , using sterol-depleted HDL, also have shown that the rate of cholesterol efflux from cultured fibroblasts saturates at 20 ,g HDL protein/ml. These results conform to the proposal that cholesterol efflux is mediated by specific high-affinity binding of HDL particles to the cell surface. Apparently, depletion of cellular cholesterol or saturation of the rate of cholesterol transport per se could not account for the saturating effects of HDL3. First, saturation of cholesterol efflux was evident in the presence of increasing concentrations of sterol-depleted HDL3 when the incubation time was short enough to allow for only partial depletion of available cellular cholesterol. Second, at concentrations that evoke maximum responses, both sterol-depleted HDL3 and VHDL (21, 37) promote cholesterol efflux to a greater extent than HDL3. Thus, the maximum amount of cholesterol that can be transported from the cell depends on both the medium concentration and physical properties of the HDL particles. In contrast to HDL3 and denser apo-AI-containing particles, HDL2, cannot promote cholesterol efflux from cultured fibroblasts (21, 38) . This is probably because HDL2 is richer in sterol than the denser subfractions and, thus, does not establish a sufficient diffusion gradient for net transport of cholesterol from cell membranes. If cholesterol efflux is mediated by binding of HDL3 to a finite number of sites on the cell surface, and if both HDL3 and HDL2 bind to these sites, then HDL2 should have the ability to block the cholesterol efflux promoted by HDL3. This proposal is supported by results showing that a mixture of apo E-free HDL2 and HDL3 had less ability to enhance degradation of '251-LDL by fibroblasts than did HDL3 alone. Other studies have demonstrated that HDL2 can block the stimulatory effects that both HDL3 and VHDL have on LDL receptor activity over both short-(4 h) and long-term (48 h) incubations (37) . Although mechanisms other than competition for the same binding sites may explain the blocking effects of HDL2, these results emphasize that the major determinant of the rate of cholesterol efflux from the cell may be the relative proportion of HDL subfractions in the extracellular environment rather than the absolute concentration of HDL particles. This hypothesis would have particular significance in vivo, where the total HDL concentration in extravascular fluids and serum is likely to be 5 to 50 times higher (39) than the concentration required to promote maximum cholesterol efflux from the cell and saturate the high-affinity HDL binding sites on the cell surface. The interaction of HDL particles with the cell surface of extrahepatic cells and the resulting effects on cell cholesterol metabolism may be related to the strong inverse correlation between serum HDL cholesterol levels and the risk for development of atherosclerosis.
